Warning! GuruFocus detected
1 Severe warning sign
with 6918.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
A Plus Biotechnology Co Ltd
ISIN : TW0006918006
Description
A Plus Biotechnology Co Ltd provides orthopedic implants. It engages in the research and development of orthopedic medical products. Aplus locking plate systems feature superior anatomical bone curves and 5-axis CNC manufacturing technology.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.67 | |||||
| Equity-to-Asset | 0.78 | |||||
| Debt-to-Equity | 0.12 | |||||
| Debt-to-EBITDA | 0.95 | |||||
| Interest Coverage | 90.4 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 8.63 | |||||
| Beneish M-Score | -2.45 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 10.4 | |||||
| 3-Year EBITDA Growth Rate | 43.4 | |||||
| 3-Year EPS without NRI Growth Rate | 64.1 | |||||
| 3-Year Book Growth Rate | 1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 49.14 | |||||
| 9-Day RSI | 44.81 | |||||
| 14-Day RSI | 46.48 | |||||
| 3-1 Month Momentum % | 25.72 | |||||
| 6-1 Month Momentum % | 28.24 | |||||
| 12-1 Month Momentum % | 81.36 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.49 | |||||
| Quick Ratio | 3.73 | |||||
| Cash Ratio | 2.4 | |||||
| Days Inventory | 802.23 | |||||
| Days Sales Outstanding | 146.69 | |||||
| Days Payable | 96.5 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.69 | |||||
| Dividend Payout Ratio | 1.06 | |||||
| Forward Dividend Yield % | 3.94 | |||||
| 5-Year Yield-on-Cost % | 2.69 | |||||
| 3-Year Average Share Buyback Ratio | -1.9 | |||||
| Shareholder Yield % | 2.84 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 68.29 | |||||
| Operating Margin % | 23.81 | |||||
| Net Margin % | 19.43 | |||||
| FCF Margin % | 37.5 | |||||
| ROE % | 8.9 | |||||
| ROA % | 6.86 | |||||
| ROIC % | 11.8 | |||||
| 3-Year ROIIC % | -92.42 | |||||
| ROC (Joel Greenblatt) % | 17.26 | |||||
| ROCE % | 10.12 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 39.49 | |||||
| PE Ratio without NRI | 39.57 | |||||
| Price-to-Owner-Earnings | 28.05 | |||||
| PEG Ratio | 4.5 | |||||
| PS Ratio | 7.67 | |||||
| PB Ratio | 3.37 | |||||
| Price-to-Tangible-Book | 3.39 | |||||
| Price-to-Free-Cash-Flow | 20.3 | |||||
| Price-to-Operating-Cash-Flow | 19.14 | |||||
| EV-to-EBIT | 28.33 | |||||
| EV-to-EBITDA | 24.89 | |||||
| EV-to-Revenue | 6.94 | |||||
| EV-to-FCF | 18.19 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.33 | |||||
| Price-to-Graham-Number | 2.44 | |||||
| Price-to-Net-Current-Asset-Value | 4.84 | |||||
| Price-to-Net-Cash | 23.12 | |||||
| Earnings Yield (Greenblatt) % | 3.53 | |||||
| FCF Yield % | 4.91 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
A Plus Biotechnology Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 404.811 | ||
| EPS (TTM) (NT$) | 2.57 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 49.75 | ||
| 14-Day RSI | 46.48 | ||
| 14-Day ATR (NT$) | 4.059857 | ||
| 20-Day SMA (NT$) | 106.665 | ||
| 12-1 Month Momentum % | 81.36 | ||
| 52-Week Range (NT$) | 57.1 - 115 | ||
| Shares Outstanding (Mil) | 30.47 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
A Plus Biotechnology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
A Plus Biotechnology Co Ltd Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
A Plus Biotechnology Co Ltd Frequently Asked Questions
What is A Plus Biotechnology Co Ltd(ROCO:6918)'s stock price today?
The current price of ROCO:6918 is NT$103.50. The 52 week high of ROCO:6918 is NT$115.00 and 52 week low is NT$57.10.
When is next earnings date of A Plus Biotechnology Co Ltd(ROCO:6918)?
The next earnings date of A Plus Biotechnology Co Ltd(ROCO:6918) is .
Does A Plus Biotechnology Co Ltd(ROCO:6918) pay dividends? If so, how much?
The Dividend Yield %  of A Plus Biotechnology Co Ltd(ROCO:6918) is 2.69% (As of Today), Highest Dividend Payout Ratio of A Plus Biotechnology Co Ltd(ROCO:6918) was 1.06. The lowest was 0.55. And the median was 0.55. The  Forward Dividend Yield % of A Plus Biotechnology Co Ltd(ROCO:6918) is 3.94%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers